The North America Colorectal Cancer Screening Market size is estimated at USD 7.15 billion in 2024, and is expected to reach USD 9.89 billion by 2029, growing at a CAGR of 6.70% during the forecast period (2024-2029).
The North American colorectal cancer screening market studied is fragmented in nature, owing to the presence of many small and large market players. Some of the key players in the North American colorectal cancer screening market are Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Novigenix SA, Siemens Healthineers, and Sysmex Corporation, among others.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook